Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $77.34M.
ENTERPRISE VALUE (EV)
$77.34M
Cartesian Therapeutics, Inc.
Market Cap
$198.33M
Enterprise Value (EV)
$77.34M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | $198.33M | $77.34M |
| Exagen Inc. (XGN)vs › | $198.84M | $199.79M |
| Surrozen, Inc. (SRZN)vs › | $197.18M | $101.46M |
| Alector, Inc. (ALEC)vs › | $200.96M | $173.80M |
| RxSight, Inc. (RXST)vs › | $192.49M | $189.72M |
| Whitehawk Therapeutics Inc (WHWK)vs › | $204.95M | $119.71M |
| Zentalis Pharmaceuticals, Inc. (ZNTL)vs › | $190.42M | $203.33M |
| Pro-Dex, Inc. (PDEX)vs › | $207.27M | $217.18M |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $189.11M | $182.77M |
| Electra Therapeutics Inc. (ETRA)vs › | $208.31M | N/A |
Market Cap
$198.33M
Total Debt
$4.15M
Cash
$125.14M
Enterprise Value
$77.34M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
